Terms: = Testicular cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1
46 results:
1. Primary retroperitoneal lymph node dissection for clinical stage II seminoma: A systematic review and meta-analysis of safety and oncological effectiveness.
Kardoust Parizi M; Margulis V; Bagrodia A; Bekku K; Klemm J; Matsukawa A; Alimohammadi A; Motlagh RS; Mostafaei H; Laukhtina E; Shariat SF
Urol Oncol; 2024 Apr; 42(4):102-109. PubMed ID: 38360519
[TBL] [Abstract] [Full Text] [Related]
2. Strong apoptotic response of testis tumor cells following cisplatin treatment.
Köberle B; Usanova S; Piee-Staffa A; Heinicke U; Clauss P; Brozovic A; Kaina B
Int Urol Nephrol; 2024 Mar; 56(3):1007-1017. PubMed ID: 37891379
[TBL] [Abstract] [Full Text] [Related]
3. Extrinsic apoptosis and senescence involved in growth kinetics of seminoma to cisplatin.
Yin Y; Peng J; Zheng X; Zhou J; Wang Y; Dai Y; Yin G; Tang Y
Clin Exp Pharmacol Physiol; 2023 Feb; 50(2):140-148. PubMed ID: 36222180
[TBL] [Abstract] [Full Text] [Related]
4. [Characterization of the men undergoing autologous sperm preservation in Chongqing Human Sperm Bank].
Huang H; Huang J; Wan L; Chen L; Wang H; Zhang Y; Yang JG
Zhonghua Nan Ke Xue; 2021 Jun; 27(6):513-516. PubMed ID: 34914290
[TBL] [Abstract] [Full Text] [Related]
5. The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells.
Camacho-Moll ME; Macdonald J; Looijenga LHJ; Rimmer MP; Donat R; Marwick JA; Shukla CJ; Carragher N; Jørgensen A; Mitchell RT
BMC Cancer; 2019 Nov; 19(1):1124. PubMed ID: 31744479
[TBL] [Abstract] [Full Text] [Related]
6. Primary robotic RLPND for nonseminomatous germ cell testicular cancer: a two-center analysis of intermediate oncologic and safety outcomes.
Rocco NR; Stroup SP; Abdul-Muhsin HM; Marshall MT; Santomauro MG; Christman MS; L'Esperance JO; Castle EP
World J Urol; 2020 Apr; 38(4):859-867. PubMed ID: 31502033
[TBL] [Abstract] [Full Text] [Related]
7. CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30
Hong LK; Chen Y; Smith CC; Montgomery SA; Vincent BG; Dotti G; Savoldo B
Cancer Immunol Res; 2018 Oct; 6(10):1274-1287. PubMed ID: 30087115
[TBL] [Abstract] [Full Text] [Related]
8. Protective mechanisms of resveratrol against methotrexate-induced renal damage may involve BCRP/ABCG2.
El-Sheikh AA; Morsy MA; Al-Taher AY
Fundam Clin Pharmacol; 2016 Oct; 30(5):406-18. PubMed ID: 27213989
[TBL] [Abstract] [Full Text] [Related]
9. Metastatic choriocarcinoma induced separate simultaneous intracerebral haemorrhages: a very rare occurrence and its novel association with Klinefelter syndrome.
Joret MO; Starke RM; Scotter J; Heppner P
BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26564116
[TBL] [Abstract] [Full Text] [Related]
10. Cisplatin resistance in germ cell tumours: models and mechanisms.
Jacobsen C; Honecker F
Andrology; 2015 Jan; 3(1):111-21. PubMed ID: 25546083
[TBL] [Abstract] [Full Text] [Related]
11. Pro- and anti-apoptotic effects of p53 in cisplatin-treated human testicular cancer are cell context-dependent.
di Pietro A; Koster R; Boersma-van Eck W; Dam WA; Mulder NH; Gietema JA; de Vries EG; de Jong S
Cell Cycle; 2012 Dec; 11(24):4552-62. PubMed ID: 23165211
[TBL] [Abstract] [Full Text] [Related]
12. Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the fas/fasL pathway.
Koster R; Timmer-Bosscha H; Bischoff R; Gietema JA; de Jong S
Cell Death Dis; 2011 Apr; 2(4):e148. PubMed ID: 21509038
[TBL] [Abstract] [Full Text] [Related]
13. Sequential X-irradiation induced acquired resistance to oxaliplatin but increased sensitivity to cisplatin in two human teratoma cell lines in vitro.
Eisenmann S; Voigt W; Müller T; Dempke W
Anticancer Res; 2010 Nov; 30(11):4471-6. PubMed ID: 21115895
[TBL] [Abstract] [Full Text] [Related]
14. LINE-1 methylation is inherited in familial testicular cancer kindreds.
Mirabello L; Savage SA; Korde L; Gadalla SM; Greene MH
BMC Med Genet; 2010 May; 11():77. PubMed ID: 20478068
[TBL] [Abstract] [Full Text] [Related]
15. Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer.
Glendenning JL; Barbachano Y; Norman AR; Dearnaley DP; Horwich A; Huddart RA
Cancer; 2010 May; 116(10):2322-31. PubMed ID: 20225230
[TBL] [Abstract] [Full Text] [Related]
16. Myocardial infarction and other major vascular events during chemotherapy for testicular cancer.
Dieckmann KP; Gerl A; Witt J; Hartmann JT;
Ann Oncol; 2010 Aug; 21(8):1607-1611. PubMed ID: 20067918
[TBL] [Abstract] [Full Text] [Related]
17. Male germ cell development: turning on the apoptotic pathways.
Tripathi R; Mishra DP; Shaha C
J Reprod Immunol; 2009 Dec; 83(1-2):31-5. PubMed ID: 19889463
[TBL] [Abstract] [Full Text] [Related]
18. Reproduction rates after cancer treatment: experience from the Norwegian radium hospital.
Cvancarova M; Samuelsen SO; Magelssen H; Fosså SD
J Clin Oncol; 2009 Jan; 27(3):334-43. PubMed ID: 19075285
[TBL] [Abstract] [Full Text] [Related]
19. Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells.
Wang WJ; Li QQ; Xu JD; Cao XX; Li HX; Tang F; Chen Q; Yang JM; Xu ZD; Liu XP
Int J Oncol; 2008 Nov; 33(5):1037-45. PubMed ID: 18949367
[TBL] [Abstract] [Full Text] [Related]
20. Expression of fas and fas ligand in human testicular germ cell tumours.
Baldini E; Ulisse S; Marchioni E; Di Benedetto A; Giovannetti G; Petrangeli E; Sentinelli S; Donnorso RP; Reale MG; Mottolese M; Gandini L; Lenzi A; D'Armiento M
Int J Androl; 2009 Apr; 32(2):123-30. PubMed ID: 17916181
[TBL] [Abstract] [Full Text] [Related]
[Next]